Getting the small steps right for our biotech customers to make an exponential difference in patients’ lives

January 13, 2021

Biotech companies are the driving force behind the industry’s R&D pipeline as they develop and launch increasingly complex treatments. With more than 80% of the assets in development managed by small and mid-sized biopharma companies, it is a thrilling time to be working in this field.

Previous Article
Creating an effective cell or gene therapy communications strategy
Creating an effective cell or gene therapy communications strategy

In this infographic, we have outlined some engagement activities that can enhance your cell or gene therapy...

Next Article
Episode 14: Why Parents and Children Join Research Studies: CISCRP’s 2020 Pediatric Perceptions & Insights Survey Reveals Critical Insights
Episode 14: Why Parents and Children Join Research Studies: CISCRP’s 2020 Pediatric Perceptions & Insights Survey Reveals Critical Insights

Pediatric participation in clinical trials is essential to understanding how drugs perform in children, who...